Mortality and Related Risk Factors After Hip Arthroplasty
Overview
The patients who underwent hip arthroplasty in our hospital from January 2017 to December 2020 were reviewed. The perioperative data were collected, and then the mortality was calculated and the risk factors were analyzed.
Full Title of Study: “Mortality and Related Risk Factors After Hip Arthroplasty, a Retrospective Study”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: August 4, 2023
Arms, Groups and Cohorts
- All patients were reviewed
Clinical Trial Outcome Measures
Primary Measures
- Risk factors of mortality one year after operation
- Time Frame: From about even days before operation to 12 months after operation
Secondary Measures
- Risk factors of lower activities of daily living score at 12 months after operation
- Time Frame: From about even days before operation to 12 months after operation
Participating in This Clinical Trial
Inclusion Criteria
- All patients undergoing hip arthroplasty in Renji Hospital during 2017.1-2020.12 Exclusion Criteria:
- Patients who did not undergo surgery after admission Age < 18 years Patients undergoing the second operation
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- RenJi Hospital
- Provider of Information About this Clinical Study
- Sponsor
- Overall Contact(s)
- Leilei WANG, master, 8618801966298, wangleilei@renji.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.